A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Verona Pharma PLC stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 265 shares of VRNA stock, worth $11,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
265
Previous 400 33.75%
Holding current value
$11,935
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.46 - $30.16 $2,087 - $4,071
-135 Reduced 33.75%
265 $7,000
Q1 2024

May 15, 2024

BUY
$15.3 - $20.24 $6,120 - $8,095
400 New
400 $6.44 Million
Q4 2022

Aug 14, 2024

SELL
$9.84 - $26.13 $2,460 - $6,532
-250 Reduced 38.46%
400 $10.5 Million
Q1 2022

Aug 14, 2024

BUY
$4.82 - $6.98 $1,205 - $1,745
250 Added 62.5%
650 $3.24 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.75B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.